Events: 9th February 2018

Federal law requires generic drug manufacturers to use the identical warning labels as their corresponding innovator or brand-name drugs, and it forbids them from updating or adding to the language authorized by the FDA when approving those products. That means generic manufacturers cannot be sued for deficient warnings when patients using their drugs are injured. … Continue reading “Inventing New Liability? Who Should We Blame When Generic Drugs Harm Patients?”